Category: ConMed Corp.Syndicate content

Acelity snares Smith & Nephew exec Agarwal | Personnel Moves

December 9, 2014 by Brad Perriello

Wound care giant Acelity says it snared Smith & Nephew's orthopedic reconstruction president Guarav Agarwal, for its newly created president of business & innovation role.

Acelity snares Smith & Nephew exec Agarwal | Personnel Moves

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA green lights Stimwave's mini spinal cord stimulator | Regulatory news for the week of December 8, 2014

December 9, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA gives the green light to Stimwave's mini spinal cord stimulator; HeartFlow wins FDA OK for non-invasive FFR system; FDA warns AngioDynamics subsidiary Navilyst on hairs in PICC packaging; Philips defib updates spur ConMed electrode recall; FDA approves J&J spinal device for rare pediatric syndrome

FDA gives the green light to Stimwave's mini spinal cord stimulator

December 3, 2014 by Mark Hollmer

Philips defib updates spur ConMed electrode recall

December 5, 2014 by Mark Hollmer

The FDA assigns Class I recall status to several lines of ConMed's defibrillator electrodes because they won't function with a number of updated devices made by Philips.

ConMed recalls defib leads that don't work with newer Philips devices

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Ex-Stryker CFO Hartman wins CEO job at ConMed | Personnel Moves

November 10, 2014 by Brad Perriello

ConMed makes ex-Stryker CEO Curt Hartman its permanent CEO after a 3-month interim period.

Ex-Stryker CFO Hartman wins CEO job at ConMed | Personnel Moves

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Will Medtronic abandon inversion in Covidien deal? | Medtech Wall Street news for the week of August 18, 2014

August 21, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; ElectroCore seeks commercial partners for non-invasive headache tech; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Activist investor battles on over ConMed as shareholders vote approaches; Medtronic's Q1 earnings beat The Street on modest sales bump

Will Medtronic follow Walgreen and abandon inversion in Covidien deal?

August 15, 2014 by Brad Perriello

Activist investor battles on over ConMed as shareholders vote approaches

August 14, 2014 by Brad Perriello

Activist investor Voce Capital Management vies for ConMed shareholders' favor as the medical device company's annual meeting approaches.

Hedge funds battle over ConMed's board as shareholders meeting approaches

Ex-Stryker CFO Hartman takes over at ConMed

July 23, 2014 by Arezu Sarvestani

ConMed names former Stryker CFO Curt Hartman interim CEO and lowers its outlook for the rest of the year.

Former Styker CFO takes over at ConMED

Surgical device maker ConMed (NSDQ:CNMD) took a major hit on Wall Street today after announcing some turnover at the top and lowering its financial outlook for the rest of the year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp